Suominen Corporation
1.10.2026 14:00:00 CEST | Globenewswire | Press release
Suominen Corporation – Manager’s transaction: Charles Héaulmé
Suominen Corporation – Manager’s transaction: Charles Héaulmé
Suominen Corporation October 1, 2026, at 3:00 p.m. (EEST)
Suominen Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Charles Héaulmé
Position: Chief Executive Officer
Issuer: Suominen Oyj
LEI: 743700Z1BNFYR9PRDF52
Notification type: INITIAL NOTIFICATION
Reference number: 174870/6/6
____________________________________________
Transaction date: 2026-09-30
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009010862
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 324000 Unit price: 0 N/A
Aggregated transactions (1):
Volume: 324000 Volume weighted average price: 0 N/A
____________________________________________
SUOMINEN CORPORATION
For further information, please contact:
Kimmo Raunio, CFO, tel. +358 10 214 3053
About Suominen Corporation
Suominen manufactures nonwovens as roll goods for wipes and other applications. Our vision is to be the frontrunner for nonwovens innovation and sustainability. The end products made of Suominen’s nonwovens are present in people’s daily life worldwide. Suominen’s net sales in 2025 were EUR 412.4 million and we have almost 700 professionals working in Europe and in the Americas. Suominen’s shares are listed on Nasdaq Helsinki. Read more at www.suominen.fi.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chemometec A/S5.10.2026 21:52:21 CEST | Press release
Major shareholder announcement - BlackRock, Inc.
Chemometec A/S5.10.2026 21:52:21 CEST | Pressemeddelelse
Storaktionærmeddelelse - BlackRock, Inc.
Tryg A/S5.10.2026 21:21:26 CEST | Pressemeddelelse
Storaktionærmeddelelse
Tryg A/S5.10.2026 21:21:26 CEST | Press release
Major Shareholder Announcement
Genmab A/S5.10.2026 20:49:00 CEST | Press release
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom